Thymosin Beta-4
£35.00
TB-500 research material, shown as a boxed pen. Cited work includes analytical detection and thymosin beta-4 or related segments.
Pen imagery is illustrative, based on supplied reference photographs. It does not verify the final supplied hardware, fill or strength.
Supplied for laboratory and scientific research only. Not for human or veterinary use.
| Name | TB-500 |
|---|---|
| Category | Research pen |
| Listed amount | 5 mg total per pen |
| Format | Boxed research pen concept — final fill and concentration are unconfirmed |
| Classification | Supplied for laboratory and scientific research only. Not for human or veterinary use. |
Free UK delivery when you spend £25 or more. Eligible in-stock orders are dispatched the same working day, with tracked delivery available to selected European destinations.
Choose your country at checkout to confirm product availability and delivery charges.
Delivery windows are estimates, not guarantees. Dispatch is not the same as delivery, and customs clearance is not controlled by Zynx.
Supporting quality documentation is displayed where available.
View quality documentation · Research-use policy · Delivery · Returns. Batch and Certificate of Analysis lookup is not available on this site.
Published papers describe research on the named compound or related molecules. They do not test, certify or endorse the specific material shown on this page, and they do not make the material approved for personal use.
Journal of Chromatography A, 2012
Study model: Equine urine and plasma analytical detection
Described analytical methods for detecting TB-500, a synthetic version of an active region of thymosin beta-4, in equine samples.
This is an identification and detection study, not an efficacy study. It does not test the listed product.
Wound Repair and Regeneration, 2003
Study model: Diabetic and aged mouse dermal wound models
Studied thymosin beta-4 and a synthetic peptide containing its actin-binding domain in mouse dermal wound models.
Research on full-length thymosin beta-4 or a related synthetic segment is not automatically evidence for every material marketed as TB-500.
